Improving diversity in future clinical trials for mHSPC

Improving Clinical Trial Diversity

Key Themes:

• A multistakeholder approach is required (patients, communities, clinicians, payers, industry).
• Community outreach initiatives are essential for building trust.
• A comprehensive approach is needed to address the barriers to participation.
• Bring clinical trial access directly into communities of color.

Key Points for Physicians:

• Support or participate in community outreach programs.
• Address practical barriers to clinical trial participation with patients.
• Consider geographical and logistical factors when referring patients to trials.
• Recognize the importance of building trust through community engagement.

Notable Insights: Creating direct conduits to high-quality care through community-based initiatives represents a practical strategy for improving trial diversity and addressing historical mistrust.

Clinical Significance: Systematic approaches to improving trial diversity are essential for generating evidence applicable to all patient populations and addressing historical health care disparities.